openbiollm
70B parameters
Commercial OK
Reviewed November 2026

OpenBioLLM Llama 3 70B

Medical / biomedical fine-tune of Llama 3 70B. Strong on USMLE and clinical-knowledge benchmarks; right pick when domain-specific medical depth matters more than general capability.

License: Llama Community License·Released Apr 26, 2024·Context: 8,192 tokens
BLK · VERDICT

Our verdict

OP · Eruo Fredoline|UPDATED NOV 8, 2026
Not tested by usEditorial assessment from specifications and published reports.
unrated

Positioning

OpenBioLLM Llama 3 70B is a 70B-parameter medical-domain fine-tune of Llama 3, designed for biomedical and clinical NLP tasks. Built on the Llama 3 70B base model with DPO fine-tuning on a custom medical instruction dataset, OpenBioLLM targets operators who need strong general language capability paired with specialized medical knowledge — without the cost and privacy concerns of commercial medical AI APIs.

Strengths

  • Medical-domain specialization on a strong 70B base. The Llama 3 70B backbone provides strong general reasoning and language capability; the medical fine-tuning adds domain-specific knowledge of drugs, diseases, treatments, anatomy, and clinical terminology.
  • Fine-tuned for biomedical NLP tasks. Designed for medical Q&A, clinical note summarization, biomedical literature analysis, drug interaction checking, and patient education material generation — the core medical NLP use cases.
  • 70B scale balances capability with deployability. Q4 at ~42 GB fits workstation hardware (Mac Studio M3 Ultra) and is accessible for healthcare organizations that need on-premise deployment for HIPAA/privacy compliance.
  • Open-weight availability enables on-premise healthcare deployment. Healthcare data privacy regulations (HIPAA, GDPR) make cloud-hosted medical AI APIs challenging. OpenBioLLM can run fully on-premise, addressing a critical deployment constraint for medical AI.
  • Llama 3 base model quality. The underlying 70B model provides strong general reasoning, allowing the model to handle mixed medical + general tasks better than purely biomedical models.
  • Competitive on medical benchmarks. Performance on MedQA, MedMCQA, PubMedQA, and clinical NLP benchmarks is competitive with other medical-domain LLMs at similar scale.

Limitations

  • Not a replacement for clinical judgment. This is an AI language model fine-tuned on medical data — it can and will make errors, hallucinate medical facts, and provide incomplete or outdated medical information. It should not be used for clinical diagnosis without human oversight and appropriate regulatory approval.
  • Medical knowledge cutoff. The fine-tuning data has a cutoff date — newer drugs, treatment protocols, and medical research published after training are not reflected. Verify knowledge recency for clinical applications.
  • Inherits Llama 3 license restrictions. The base Llama 3 model carries Meta's license with the 700M MAU clause and use restrictions. Verify compatibility with your healthcare deployment context.
  • Regulatory compliance is operator's responsibility. This model has not undergone FDA, CE, or other medical device regulatory approval. Operators deploying in clinical contexts must handle regulatory compliance independently.
  • Domain coverage may not span all medical specialties. The fine-tuning data likely emphasizes common medical domains (internal medicine, cardiology, oncology) over rare specialties. Performance on niche medical domains may be limited.
  • No vision or multimodal medical capability. Text-only. Cannot analyze medical images (X-rays, MRIs, pathology slides). For medical image analysis, consider specialized vision models.

Real-world performance

  • vs Llama 3.3 70B (general purpose): OpenBioLLM is tuned for medical-domain tasks. Llama 3.3 70B wins general tasks. OpenBioLLM is a medical specialist on a general-purpose base that retains Llama's general capability as a fallback.
  • vs GPT-4 (medical API): Closed-source medical AI APIs (GPT-4 with medical fine-tuning, Med-PaLM) have broader knowledge, more rigorous safety evaluation, and regulatory pathways. OpenBioLLM's clear advantage is on-premise deployment and privacy control. Its model card reports a higher average than GPT-4 (86.06 vs 82.85) and 5-shot Med-PaLM 2 (84.08) across 9 biomedical datasets, which is the maker's own comparison.
  • vs Tulu 3 70B: Both Llama 3-based fine-tunes. Tulu 3 is for general instruction-following; OpenBioLLM is for medical domain tasks. Different specialization targets.

Should you run this locally?

Yes if you're deploying medical AI in a privacy-regulated context (HIPAA, GDPR) requiring on-premise inference, have workstation-class hardware, and accept the model's limitations as a language model — not a clinical decision system. The on-premise deployment capability is the primary advantage over medical AI APIs.

No if you need regulatory-approved medical AI, require medical image analysis capability, or can use cloud-hosted medical AI APIs with appropriate data processing agreements (BAA in HIPAA context). Also no if the Llama 3 base license conflicts with your healthcare deployment.

How it compares

  • vs Llama 3.3 70B: Medical specialist vs generalist. OpenBioLLM wins medical tasks; Llama 3.3 wins general tasks.
  • vs Tulu 3 70B: Different fine-tuning domains — medical vs general instruction-following.
  • vs Gemma 4 31B: OpenBioLLM is larger (70B vs 31B) and medical-specialized; Gemma is general-purpose with different license.
  • vs Medical AI APIs: OpenBioLLM wins on-premise deployment and privacy; APIs win regulatory readiness and broader medical knowledge.

Run this yourself

  • Datacenter: Single A100 80GB at FP8 with vLLM.
  • Workstation: Mac Studio M3 Ultra (96 GB or 256 GB) at Q4: comfortable fit.
  • On-premise healthcare: HIPAA-compliant server with A100 80GB or Mac Studio.
  • Vendor: huggingface.co/aaditya/Llama3-OpenBioLLM-70B

Overview

Medical / biomedical fine-tune of Llama 3 70B. Strong on USMLE and clinical-knowledge benchmarks; right pick when domain-specific medical depth matters more than general capability.

How to run it

OpenBioLLM-Llama-3-70B is a biomedical domain-specialized fine-tune of Llama 3 70B. Fine-tuned on a custom medical instruction dataset. Run at Q4_K_M via llama.cpp with -ngl 999 -fa -c 4096. The official Ollama library has no OpenBioLLM tag. Q4_K_M file size ~40 GB on disk. Minimum VRAM: 48 GB — RTX A6000 (48GB) at Q4_K_M for 4K context. RTX 4090 24GB: partial CPU offload only. Recommended: A100 80GB at AWQ-INT4. Standard Llama 3 architecture — compatible with all Llama inference stacks. Biomedical specialization means the model is significantly better at medical terminology, drug names, clinical reasoning, and literature summarization than base Llama 3 70B. But general knowledge outside biomedicine may be degraded due to catastrophic forgetting from domain fine-tuning. Use for: medical Q&A, clinical note summarization, biomedical research assistance, drug interaction checking. Not for: general chat, coding, creative writing. License: verify on huggingface.co/aaditya/Llama3-OpenBioLLM-70B.

Hardware guidance

Minimum: RTX 3090 24GB with partial CPU offload only, since Q3_K_M weights are about 34 GB. Recommended: RTX A6000 48GB at Q4_K_M (8K). Optimal: A100 80GB at AWQ-INT4. VRAM math: identical to base Llama 3 70B: 70B dense at Q4_K_M ≈ 40 GB. KV cache at 8K: ~2.7 GB (80 layers x 2 x 8 KV heads x 128 head dim x 2 bytes x 8,192 tokens). Total ~43 GB, which fits an A6000 48GB at 8K. RTX 4090 24GB: partial CPU offload only. Dual RTX 4090 48 GB: Q4 at 8K. Mac Studio M4 Max 64GB: Q4_K_M. Cloud: A100 80GB. The config's max_position_embeddings is 8,192, so 8K is the context limit. Biomedicine-specific prompts are typically shorter (2-4K tokens) than general chat — less context pressure.

What breaks first

  1. Catastrophic forgetting. Domain fine-tuning on biomedical data degrades general knowledge. The model will hallucinate more on non-biomedical topics than base Llama 3 70B. 2. Medical accuracy liability. OpenBioLLM is a research model — not FDA-approved, not clinically validated. Medical outputs may be incorrect, outdated, or dangerous. Never use for clinical decision-making without human review. 3. Terminology precision at low quants. Medical terminology is precise — Q3 quantization may confuse drug names, dosages, or anatomical terms. Use Q4_K_M minimum for medical use. 4. Training data recency. Biomedical knowledge has a cutoff date from the fine-tuning data. New drugs, treatments, and guidelines published after the cutoff won't be known. Supplement with RAG on current literature.

Runtime recommendation

The official Ollama library has no OpenBioLLM tag, so Ollama needs a GGUF import. llama.cpp for local use. vLLM for serving. Standard Llama architecture — any Llama-compatible stack works. For RAG: pair with a biomedical vector database (PubMed embeddings) for current literature grounding.

Common beginner mistakes

Mistake: Using OpenBioLLM for general medical advice as a production clinical tool. Fix: This is a research model. Always verify outputs against current medical guidelines. Never deploy for clinical decision-making without physician review. Mistake: Expecting OpenBioLLM to know about drugs released after its training cutoff. Fix: The model's knowledge is frozen at training time. Use RAG with current PubMed/clinical databases for recent information. Mistake: Using Q3 quantization for biomedical tasks. Fix: Q3 degrades terminology precision. Use Q4_K_M minimum. Q8 or FP16 if precision is critical. Mistake: Comparing OpenBioLLM to general-purpose models on non-medical benchmarks. Fix: OpenBioLLM is domain-specialized. It will underperform on general benchmarks compared to same-sized general models. Test only on biomedical tasks.

Family & lineage

How this model relates to others in its lineage. Family members share architecture and training-data roots; parent / children edges record direct distillation or fine-tune relationships.

Strengths

  • Strongest open medical-domain model in 70B class
  • Llama 3 base — broad runtime support

Weaknesses

  • Domain-specialized: general chat quality trails general-purpose models such as Llama 3.3 70B

Quantization variants

Each quantization trades model quality for file size and VRAM. Q4_K_M is the most popular starting point.

QuantizationFile sizeVRAM required
Q4_K_M42.0 GB48 GB
Rent instead
Too big for a 32 GB card? Rent a GPU by the hour

At Q4 OpenBioLLM Llama 3 70B needs about 48 GB of memory by our estimate, more than a 32 GB graphics card holds. Renting a GPU with enough memory (or several GPUs) by the hour is the practical way to try it before you plan hardware for it.

Referral links: RunLocalAI may earn a commission or account credits if you sign up and rent, at no extra cost to you. Hourly rates and which GPUs are listed change all the time, so check the provider's page before you start. How we make money.

Get the model

HuggingFace

Original weights

huggingface.co/aaditya/Llama3-OpenBioLLM-70B

Source repository — direct quantization required.

Hardware that runs this

Cards with enough VRAM for at least one quantization of OpenBioLLM Llama 3 70B.

Compare alternatives

Models worth comparing

Same parameter band, plus what's one tier above and below — so you can decide what actually fits your hardware.

Frequently asked

What's the minimum VRAM to run OpenBioLLM Llama 3 70B?

48GB of VRAM is enough to run OpenBioLLM Llama 3 70B at the Q4_K_M quantization (file size 42.0 GB). Higher-quality quantizations need more.

Can I use OpenBioLLM Llama 3 70B commercially?

Yes — OpenBioLLM Llama 3 70B ships under the Llama Community License, which permits commercial use. Always read the license text before deployment.

What's the context length of OpenBioLLM Llama 3 70B?

OpenBioLLM Llama 3 70B supports a context window of 8,192 tokens (about 8K).

Source: huggingface.co/aaditya/Llama3-OpenBioLLM-70B

Reviewed by RunLocalAI Editorial. See our editorial policy for how we research and verify model claims.

Related — keep moving

Before you buy

Verify OpenBioLLM Llama 3 70B runs on your specific hardware before committing money.